|
|
|
Articles |
|
|
|
Blockchain promises immutable records for biopharma data integrity, but practical value depends on use case. This article evaluates blockchain in clinical trials, supply chains, and manufacturing—highlighting pilots... |
M&A, Partnerships & Ecosystem Models in Biopharma |
| Why the Future of Biologics Will Depend as Much on Partnerships as on Molecules
|
| Surbhi Gupta,
Industry Principal, Healthcare & Life Sciences, Frost & Sullivan
|
|
|
The article will address how biopharma companies are combining manufacturing scale, regulatory collaboration, skilled talent, funding access, and public-private partnerships to strengthen biologics... |
|
Interviews |
|
|
|
This expert talk explores sustainable paradigms in pharmaceutical formulation, focusing on "Green" drug delivery. By integrating... |
|
|
